OKUR Insider Trading Activity and SEC Form 4 Filings
OKUR insider trading summary
Over the past 12 months, insiders at OnKure Therapeutics, Inc. (OKUR) reported 8 sales worth $6K by 2 insiders and no open-market purchases on SEC Form 4. Net insider selling was $6K.
Latest OKUR insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Sep 21, 2026 | Nicholas A Saccomano | President and CEO | Sell | $259 (87 @ $2.97) |
| Sep 21, 2026 | Jason A. Leverone | Chief Financial Officer | Sell | $898 (302 @ $2.97) |
| Jun 22, 2026 | Nicholas A Saccomano | President and CEO | Sell | $378 (86 @ $4.40) |
| Jun 22, 2026 | Jason A. Leverone | Chief Financial Officer | Sell | $1K (303 @ $4.40) |
| Mar 23, 2026 | Nicholas A Saccomano | President and CEO | Sell | $357 (86 @ $4.16) |
| Mar 23, 2026 | Jason A. Leverone | Chief Financial Officer | Sell | $1K (301 @ $4.16) |
| Dec 22, 2025 | Nicholas A Saccomano | President and CEO | Sell | $258 (87 @ $2.97) |
| Dec 22, 2025 | Jason A. Leverone | Chief Financial Officer | Sell | $896 (302 @ $2.97) |
| Sep 22, 2025 | Nicholas A Saccomano | President and CEO | Sell | $231 (88 @ $2.62) |
| Sep 22, 2025 | Jason A. Leverone | Chief Financial Officer | Sell | $795 (303 @ $2.62) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.